Fiber atrophy, oxidative stress, and oxidative fiber reduction are the attributes of different phenotypes in chronic obstructive pulmonary disease patients

Journal of Applied Physiology

Volumn 115, Issue 12, 2013, Pages 1796-1805

  Gouzi, Fares ^a,b   Abdellaoui, Aldjia ^a,c   Molinari, Nicolas ^a   Pinot, Edith ^a   Ayoub, Bronia ^a   Laoudj Chenivesse, Dalila ^a   Cristol, Jean Paul ^a   Mercier, Jacques ^a   Hayot, Maurice ^a   Préfaut, Christian ^a  

^a UNIV MONTPELLIER   (France)

^b Pulmonary Rehabilitation Center la Solane   (France)

^c Fontalvie Group   (France)

Author keywords

Atrophy; Cluster analysis; Muscle dysfunction; Oxidative stress; Physical activity

Indexed keywords

MUSCLE PROTEIN;

AGED; ARTICLE; ATROPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUSTER ANALYSIS; ENDURANCE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MUSCLE ATROPHY; MUSCLE DISEASE; MUSCLE DYSFUNCTION; OXIDATIVE STRESS; PATHOLOGY; PHENOTYPE; PHYSICAL ACTIVITY; PHYSIOLOGY; SKELETAL MUSCLE;

ATROPHY; CLUSTER ANALYSIS; MUSCLE DYSFUNCTION; OXIDATIVE STRESS; PHYSICAL ACTIVITY;

AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCULAR ATROPHY; MUSCULAR DISEASES; OXIDATIVE STRESS; PHENOTYPE; PHYSICAL ENDURANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84891274935     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00778.2013     Document Type: Article

References (56)

1. ATS. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 166: 111-117, 2002.
2. ATS/ACCP. ATS/ACCCP statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 167: 211-277, 2003.
3. Abdellaoui A, Prefaut C, Gouzi F, Couillard A, Coisy-Quivy M, Hugon G, Molinari N, Lafontaine T, Jonquet O, Laoudj-Chenivesse D, Hayot M. Skeletal muscle effects of electrostimulation after COPD exacerbation: A pilot study. Eur Respir J 38: 781-788, 2011.
4. Agusti A, Morla M, Sauleda J, Saus C, Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 59: 483-487, 2004.
5. Barreiro E, Gea J, Corominas JM, Hussain SN. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 29: 771-778, 2003.
6. Barreiro E, Hussain SN. Protein carbonylation in skeletal muscles: Impact on function. Antioxid Redox Signal 12: 417-429, 2010.
7. Barreiro E, Sieck G. Muscle dysfunction in COPD. J Appl Physiol 114: 1220-1221, 2013.
8. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 54: 581-586, 1999.
9. Burgel PR, Paillasseur JL, Caillaud D, Tillie-Leblond I, Chanez P, Escamilla R, Court-Fortune I, Perez T, Carre P, Roche N. Clinical COPD phenotypes: A novel approach using principal component and cluster analyses. Eur Respir J 36: 531-539, 2010.
10. Burgel PR, Paillasseur JL, Peene B, Dusser D, Roche N, Coolen J, Troosters T, Decramer M, Janssens W. Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality. PLoS One 7: E51048, 2012.
11. Burtin C, Decramer M, Gosselink R, Janssens W, Troosters T. Rehabilitation and acute exacerbations. Eur Respir J 38: 702-712, 2011.
12. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, Pinto Plata V, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350: 1005-1012, 2004.
13. Couillard A, Maltais F, Saey D, Debigare R, Michaud A, Koechlin C, LeBlanc P, Prefaut C. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167: 1664-1669, 2003.
14. Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: Potential contribution of oxidative stress. Eur Respir J 26: 703-719, 2005.
15. Delample D, Durand F, Severac A, Belghith M, Mas E, Michel F, Cristol JP, Hayot M, Prefaut C. Implication of xanthine oxidase in muscle oxidative stress in COPD patients. Free Radic Res 42: 807-814, 2008.
16. Eliason G, Abdel-Halim S, Arvidsson B, Kadi F, Piehl-Aulin K. Physical performance and muscular characteristics in different stages of COPD. Scand J Med Sci Sports 19: 865-870, 2009.
17. Fermoselle C, Rabinovich R, Ausin P, Puig-Vilanova E, Coronell C, Sanchez F, Roca J, Gea J, Barreiro E. Does oxidative stress modulate limb muscle atrophy in severe COPD patients Eur Respir J 40: 851-862, 2012.
18. Garcia-Aymerich J, Gomez FP, Benet M, Farrero E, Basagana X, Gayete A, Pare C, Freixa X, Ferrer J, Ferrer A, Roca J, Galdiz JB, Sauleda J, Monso E, Gea J, Barbera JA, Agusti A, Anto JM. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 66: 430-437, 2011.
19. Gosker HR, Engelen MP, van Mameren H, van Dijk PJ, van der Vusse GJ, Wouters EF, Schols AM. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 76: 113-119, 2002.
20. Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: A systematic review and meta-analysis. Thorax 62: 944-949, 2007.
21. Gouzi F, Maury J, Molinari N, Pomies P, Mercier J, Prefaut CG, Hayot M. Reference values for vastus lateralis fiber size and type in healthy subjects over 40 years old: A systematic review and meta-analysis. J Appl Physiol 115: 346-354, 2013.
22. Gouzi F, Prefaut C, Abdellaoui A, Roudier E, de Rigal P, Molinari N, Laoudj-Chenivesse D, Mercier J, Birot O, Hayot M. Blunted muscle angiogenic training-response in COPD patients versus sedentary controls. Eur Respir J 41: 806-814, 2013.
23. Gouzi F, Prefaut C, Abdellaoui A, Vuillemin A, Molinari N, Ninot G, Caris G, Hayot M. Evidence of an early physical activity reduction in chronic obstructive pulmonary disease patients. Arch Phys Med Rehabil 92: 1611-1617, 2011.
24. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, Fabbri LM, Goldin JG, Jones PW, Macnee W, Make BJ, Rabe KF, Rennard SI, Sciurba FC, Silverman EK, Vestbo J, Washko GR, Wouters EF, Martinez FJ. Chronic obstructive pulmonary disease phenotypes: The future of COPD. Am J Respir Crit Care Med 182: 598-604, 2010.
25. Hayot M, Michaud A, Koechlin C, Caron MA, Leblanc P, Prefaut C, Maltais F. Skeletal muscle microbiopsy: A validation study of a minimally invasive technique. Eur Respir J 25: 431-440, 2005.
26. Ho TK, Rajkumar V, Black CM, Abraham DJ, Baker DM. Increased angiogenic response but deficient arteriolization and abnormal microvessel ultrastructure in critical leg ischaemia. Br J Surg 93: 1368 -1376, 2006.
27. Hopkinson NS, Tennant RC, Dayer MJ, Swallow EB, Hansel TT, Moxham J, Polkey MI. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 8: 25, 2007.
28. Jolliffe I. Principal Component Analysis. New York: Springer, 2002, p. 90-101.
29. Keranis E, Makris D, Rodopoulou P, Martinou H, Papamakarios G, Daniil Z, Zintzaras E, Gourgoulianis KI. Impact of dietary shift to higher-antioxidant foods in COPD: A randomised trial. Eur Respir J 36: 774-780, 2010.
30. Koechlin C, Maltais F, Saey D, Michaud A, LeBlanc P, Hayot M, Prefaut C. Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive pulmonary disease. Thorax 60: 834 -841, 2005.
31. Kyle UG, Genton L, Karsegard L, Slosman DO, Pichard C. Single prediction equation for bioelectrical impedance analysis in adults aged 20-94 years. Nutrition 17: 248-253, 2001.
32. Marin-Corral J, Minguella J, Ramirez-Sarmiento AL, Hussain SN, Gea J, Barreiro E. Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients. Eur Respir J 33: 1309-1319, 2009.
33. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166: 809 -813, 2002.
34. Natanek SA, Gosker HR, Slot IG, Marsh GS, Hopkinson NS, Man WD, Tal-Singer R, Moxham J, Kemp PR, Schols NM, Polkey MI. Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratified medicine Muscle Nerve 2013.
35. Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, Macera CA, Castaneda-Sceppa C. Physical activity and public health in older adults: Recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 39: 1435-1445, 2007.
36. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, Garvey C, Goldstein R, Gosselink R, Lareau S, MacIntyre N, Maltais F, Morgan M, O'Donnell D, Prefault C, Reardon J, Rochester C, Schols A, Singh S, Troosters T. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173: 1390-1413, 2006.
37. Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M, Shimizu K, Betsuyaku T, Ito YM, Fuke S, Igarashi T, Akiyama Y, Ogura S. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185: 44-52, 2011.
38. Pifferi M, Bush A, Pioggia G, Caramella D, Tartarisco G, Di Cicco M, Zangani M, Chinellato I, Maggi F, Tezza G, Macchia P, Boner A. Evaluation of pulmonary disease using static lung volumes in primary ciliary dyskinesia. Thorax 67: 993-999, 2012.
39. Poulain M, Durand F, Palomba B, Ceugniet F, Desplan J, Varray A, Prefaut C. 6-minute walk testing is more sensitive than maximal incremental cycle testing for detecting oxygen desaturation in patients with COPD. Chest 123: 1401-1407, 2003.
40. Powers SK, Kavazis AN, McClung JM. Oxidative stress and disuse muscle atrophy. J Appl Physiol 102: 2389-2397, 2007.
41. Preacher KJ, MacCallum RC. Exploratory factor analysis in behavior genetics research: Factor recovery with small sample sizes. Behav Genet 32: 153-161, 2002.
42. Préfaut C, Gautier-Dechaud V, Fuchs-Climent D, Poulain M. Quality of life in patients with chronic obstructive pulmonary disease on long-term oxygen therapy: Role of exercise training. Human Kinetics 15: 177-186, 2000.
43. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van der Molen T, Marciniuk DD, Denberg T, Schunemann H, Wedzicha W, MacDonald R, Shekelle P. Diagnosis and management of stable chronic obstructive pulmonary disease: A clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 155: 179-191, 2011.
44. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal Official Statement of the European Respiratory Society. Eur Respir J Suppl 16: 5-40, 1993.
45. Remels AH, Gosker HR, Langen RC, Schols AM. The mechanisms of cachexia underlying muscle dysfunction in COPD. J Appl Physiol 114: 1253-1262, 2013.
46. Serres I, Varray A, Vallet G, Micallef JP, Prefaut C. Improved skeletal muscle performance after individualized exercise training in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil 17: 232-238, 1997.
47. Seymour JM, Ward K, Sidhu PS, Puthucheary Z, Steier J, Jolley CJ, Rafferty G, Polkey MI, Moxham J. Ultrasound measurement of rectus femoris cross-sectional area and the relationship with quadriceps strength in COPD. Thorax 64: 418-423, 2009.
48. Smuder AJ, Kavazis AN, Hudson MB, Nelson WB, Powers SK. Oxidation enhances myofibrillar protein degradation via calpain and caspase-3. Free Radic Biol Med 49: 1152-1160, 2010.
49. Smuder AJ, Kavazis AN, Min K, Powers SK. Exercise protects against doxorubicin-induced oxidative stress and proteolysis in skeletal muscle. J Appl Physiol 110: 935-942, 2011.
50. Steele BG, Holt L, Belza B, Ferris S, Lakshminaryan S, Buchner DM. Quantitating physical activity in COPD using a triaxial accelerometer. Chest 117: 1359-1367, 2000.
51. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, Moore AJ, Moxham J, Polkey MI. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 62: 115-120, 2007.
52. Vallet G, Ahmaidi S, Serres I, Fabre C, Bourgouin D, Desplan J, Varray A, Prefaut C. Comparison of two training programmes in chronic airway limitation patients: Standardized versus individualized protocols. Eur Respir J 10: 114-122, 1997.
53. van den Borst B, Slot IG, Hellwig VA, Vosse BA, Kelders MC, Barreiro E, Schols AM, Gosker HR. Loss of quadriceps muscle oxida-tive phenotype and decreased endurance in patients with mild-to-moderate COPD. J Appl Physiol 114: 1319-1328, 2013.
54. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op 't Roodt J, Wouters EF, Franssen FM. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 187: 728-735, 2013.
55. Vogiatzis I, Simoes DC, Stratakos G, Kourepini E, Terzis G, Manta P, Athanasopoulos D, Roussos C, Wagner PD, Zakynthinos S. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J 36: 301-310, 2010.
56. Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA. A physical activity questionnaire for the elderly. Med Sci Sports Exerc 23: 974-979, 1991.